Dr. Ying Liu has more than 30 years of clinical experience in pediatric hematology and oncology and is a highly experienced senior expert in the diagnosis and comprehensive management of childhood leukemia and lymphoma in China. She previously served for over two decades in the Pediatric Hematology & Oncology Department of the PLA General Hospital, where she built solid expertise in chemotherapy system design, critical care management, and the treatment of complex hematologic malignancies in children. Since joining Beijing GoBroad Boren Hospital in 2019, she has remained a key clinical leader and a core contributor to the department’s development.
Dr. Liu is skilled in the standardized management of pediatric acute and chronic leukemias, pediatric lymphomas, and various rare hematologic disorders. She has extensive experience in immuno-targeted therapy, intensive chemotherapy, multidisciplinary critical care, and long-term disease management. In recent years, she has been deeply involved in pediatric CAR-T therapy and multiple clinical studies in cellular immunotherapy, actively advancing the application of cutting-edge immune therapies in children with relapsed or refractory hematologic malignancies.
As a member of several national and provincial professional committees, Dr. Liu contributes significantly to the development of standardized pediatric hematology-oncology guidelines in China and participates in multiple clinical research programs. She also serves as an editorial board member of the Chinese Journal of Pediatric Hematology and Oncology, continuously promoting academic exchange and clinical advancement in the field.
